A detailed history of Sol Capital Management CO transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Sol Capital Management CO holds 14,100 shares of TEVA stock, worth $233,637. This represents 0.03% of its overall portfolio holdings.

Number of Shares
14,100
Previous 14,100 -0.0%
Holding current value
$233,637
Previous $229,000 10.92%
% of portfolio
0.03%
Previous 0.03%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 26, 2023

BUY
$7.2 - $9.47 $13,536 - $17,803
1,880 Added 15.38%
14,100 $106,000
Q4 2022

Jan 24, 2023

SELL
$7.95 - $9.48 $58,830 - $70,152
-7,400 Reduced 37.72%
12,220 $0
Q3 2022

Oct 12, 2022

SELL
$6.86 - $11.95 $13,720 - $23,900
-2,000 Reduced 9.25%
19,620 $158,000
Q2 2022

Jul 21, 2022

SELL
$7.38 - $10.4 $82,641 - $116,459
-11,198 Reduced 34.12%
21,620 $163,000
Q1 2022

Apr 18, 2022

SELL
$7.33 - $9.39 $81,363 - $104,229
-11,100 Reduced 25.27%
32,818 $308,000
Q3 2021

Oct 26, 2021

SELL
$8.38 - $10.18 $5,447 - $6,617
-650 Reduced 1.46%
43,918 $428,000
Q4 2020

Jan 22, 2021

SELL
$8.61 - $11.04 $24,108 - $30,911
-2,800 Reduced 5.91%
44,568 $430,000
Q3 2020

Oct 23, 2020

SELL
$8.57 - $12.69 $17,140 - $25,380
-2,000 Reduced 4.05%
47,368 $427,000
Q2 2020

Jul 31, 2020

BUY
$8.12 - $13.12 $1,217 - $1,967
150 Added 0.3%
49,368 $609,000
Q1 2020

Apr 22, 2020

SELL
$6.69 - $13.45 $13,380 - $26,900
-2,000 Reduced 3.9%
49,218 $442,000
Q4 2019

Jan 27, 2020

SELL
$6.53 - $10.72 $268,539 - $440,849
-41,124 Reduced 44.53%
51,218 $502,000
Q3 2019

Oct 21, 2019

SELL
$6.16 - $9.6 $147,070 - $229,200
-23,875 Reduced 20.54%
92,342 $635,000
Q2 2019

Jul 17, 2019

SELL
$8.12 - $15.72 $7,307 - $14,148
-900 Reduced 0.77%
116,217 $1.07 Million
Q1 2019

Apr 30, 2019

SELL
$15.58 - $20.01 $62,320 - $80,040
-4,000 Reduced 3.3%
117,117 $1.84 Million
Q4 2018

Jan 25, 2019

SELL
$14.59 - $23.84 $88,269 - $144,232
-6,050 Reduced 4.76%
121,117 $1.87 Million
Q3 2018

Oct 29, 2018

SELL
$21.06 - $25.65 $22,702 - $27,650
-1,078 Reduced 0.84%
127,167 $2.74 Million
Q2 2018

Jul 11, 2018

SELL
$16.77 - $24.71 $5,349 - $7,882
-319 Reduced 0.25%
128,245 $3.12 Million
Q1 2018

Apr 25, 2018

SELL
$16.68 - $22.07 $50,457 - $66,761
-3,025 Reduced 2.3%
128,564 $2.2 Million
Q4 2017

Jan 31, 2018

BUY
$11.23 - $19.1 $139,611 - $237,451
12,432 Added 10.43%
131,589 $2.49 Million
Q3 2017

Oct 27, 2017

BUY
$15.41 - $32.17 $1.84 Million - $3.83 Million
119,157
119,157 $2.1 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Sol Capital Management CO Portfolio

Follow Sol Capital Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sol Capital Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Sol Capital Management CO with notifications on news.